Skip to main content

Table 5 Ki67 expression and change value of CNB and SRS among molecular subtypes

From: Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients

  No. Median Ki67 (IQR) Mean Ki67(SD)
Luminal A 73   
  CNB   10 (5, 10) 8.2 (4.1)
  SRS   10 (10, 20) 14.5 (9.6)
  Ki67 changea   5 (0, 10) 6.3 (8.6)
Luminal B HER2- 109   
  CNB   20 (10, 40) 26.9 (19.5)
  SRS   20 (10, 30) 26.9 (19.2)
  Ki67 changea   0 (-10, 10) -0.1 (12.8)
Luminal B HER2+ 33   
  CNB   20 (10, 50) 30.2 (20.7)
  SRS   30 (15, 55) 33.5 (20.0)
  Ki67 changea   0 (-10, 14.5) 3.3 (15.1)
Triple negative 35   
  CNB   60 (30, 80) 54.1 (26.4)
  SRS   70 (30, 80) 57.4 (25.8)
  Ki67 changea   0 (-10, 10) 3.3 (13.5)
HER2 positive 26   
  CNB   25 (20, 40) 31.2 (17.3)
  SRS   30 (23.75, 50) 35.4 (15.1)
  Ki67 changea   5 (-1.25, 20.0) 4.2 (19.6)
  1. aKi67 change, SRS minus CNB
  2. Abbreviation: CNB core needle biopsy, IQR inter quartile range, SRS surgically removed samples, SD standard deviation